<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.2" -->
<rss version="0.92">
<channel>
	<title>Dissolution Solutions Network</title>
	<link>http://www.dissolutionsolutions.net</link>
	<description>News, Stories and Commentary from the Pharma Lab</description>
	<lastBuildDate>Tue, 07 Sep 2010 12:06:16 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Merck &amp; Co postpones closures</title>
		<description><![CDATA[&#8220;U.S. drugmaker Merck &#38; Co postponed on Thursday the  planned closures of some Dutch operations announced in July while it negotiates  with executives and workers on potential alternatives. The last-minute deal averts a court hearing that had been scheduled for  Thursday afternoon, at which employees of the Dutch unit, formerly called  [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=584</link>
			</item>
	<item>
		<title>From our Friends at LCGC&#8230;Their latest Tweet!</title>
		<description><![CDATA[A tweet on New Horizons in Reversed-Phase Chromatography http://ow.ly/2iJz3
&#8220;In  the latest LCGC North America high performance liquid  chromatography (HPLC) column survey (1), over 95% of all respondents  used reversed-phase chromatography  in their daily work. The popularity of this technique is undoubtedly  due to its versatility. Reversed-phase chromatography  can separate [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=578</link>
			</item>
	<item>
		<title>Senior Medical Writer – Medical Communications – London</title>
		<description><![CDATA[As pharmaceutical scientists in today&#8217;s economy, we are often challenged to expand our scope. It the past we pigeonholed ourselves into lab only type carrers. Opportunities that one may have passed up in 2005 are now considered. Scientific writers are a rare breed. One who has a mind for science and a flair for communication. [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=575</link>
			</item>
	<item>
		<title>Astellas Pharma Closing Two N.Y. Facilities By June 2011</title>
		<description><![CDATA[&#8220;Astellas Pharma Inc. is planning to close two facilities in New York that had been operated by OSI Pharmaceuticals Inc., which the Japanese drug maker bought for $4 billion in June. An Astella spokeswoman said that OSI&#8217;s Ardsley and Melville facilities will close by June 2011, affecting about 150 workers at those sites&#8230;more&#8220;
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=570</link>
			</item>
	<item>
		<title>AstraZeneca Hopeful for Positive FDA Call on Blood-Thinner but Doubts Linger</title>
		<description><![CDATA[&#8220;An FDA advisory committee’s strong vote in favor of AstraZeneca’s (AZN) blood-thinner Brilinta was tempered by long-held concerns over the failure of the drug’s pivotal trial to show a survival benefit in the US population when compared to Plavix (Event &#8211; Brilinta has questions to answer, July 21, 2010). With adcom members raising concerns over [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=567</link>
			</item>
	<item>
		<title>Sanofi fights FDA approval of generic Lovenox</title>
		<description><![CDATA[&#8220;The FDA has approved the first generic version of the blockbuster low molecular weight heparin Lovenox (enoxaparin sodium), much to originator sanofi-aventis’s displeasure. Sanofi has expressed concerns about the generic’s safety and, according to a report from Reuters, has even asked a court to block the approval, claiming that the FDA’s decision was “arbitrary and [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=564</link>
			</item>
	<item>
		<title>BioSpace Career Fair &#8212; Where Life Meets Science</title>
		<description><![CDATA[Looking for a new job? BioSpace is proud to present the Genetown Career Fair, an opportunity to
meet face-to-face with top companies in the biopharmaceutical market and network with industry
peers. 
Genetown Career Fair
Thursday, June 10, 2010
11am to 4pm
Sheraton Boston
Boston, MA
Pre-Register Now: http://news2.biospace.com/ct.html?rtr=on&#38;s=7cmna,dawx,mog,l564,fmqo,i4&#215;5,47tn
Attend the Genetown Career Fair!
Job seekers can spend a day with HR representatives and Hiring [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=560</link>
			</item>
	<item>
		<title>AstraZeneca settles kickback marketing case</title>
		<description><![CDATA[&#8220;Pharmaceutical giant AstraZeneca will pay $520 million to settle allegations that the company illegally marketed an antipsychotic drug and paid kickbacks to physicians, the Justice Department announced Tuesday&#8230;more.&#8221;
&#8212;&#8212;&#8212;&#8212;&#8211;
Editor&#8217;s Comments: They used to be a great company when they were Astra. But it seems like they have become another greedy corporate entity. Zeneca changed their direction.
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=553</link>
			</item>
	<item>
		<title>Sterling Life Sciences RandD and Manufacturing Jobs</title>
		<description><![CDATA[*Senior Director, Analytical Technical Support (Pennsylvania)
*Director, Laboratory Operations Support Services (Ontario)
*Process Engineer (California)
*Senior Director, Applications Development (California)
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=510</link>
			</item>
	<item>
		<title>BIO Career Fair</title>
		<description><![CDATA[BIO Career Fair 
Hyatt Regency Chicago &#8211; East Wacker Drive
Monday, May 3rd 2pm &#8211; 7pm
The BIO Career Fair will be held on May 3rd in conjunction with the 2010 BIO International Convention, May 3-6 in Chicago.
The BIO Career Fair is intended for professionals in the bioscience industry. Job seekers can spend the afternoon with regional, [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=540</link>
			</item>
	<item>
		<title>New Guidance: Dissolution Test General Chapter</title>
		<description><![CDATA[Guidance for Industry
_________________________________
Q4B Evaluation and Recommendation
of Pharmacopoeial Texts for Use in the ICH Regions
Annex 7
Dissolution Test General Chapter
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=534</link>
			</item>
	<item>
		<title>Abbott To Acquire Facet Biotech</title>
		<description><![CDATA[Abbott has agreed to acquire Facet Biotech for $27 per share in cash for a net transaction value of approximately $450m to enhance its early- and mid-stage pharmaceutical pipeline.
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=532</link>
			</item>
	<item>
		<title>NIH and FDA Announce Collaborative Initiative to Fast-track Innovations to the Public</title>
		<description><![CDATA[  &#8220;The U.S. Food and Drug Administration and the National Institutes of Health today unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.&#8221;
&#8220;The initiative involves two interrelated scientific disciplines: translational science, the shaping of basic scientific discoveries into treatments; and regulatory science, [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=520</link>
			</item>
	<item>
		<title>Sterling Life Sciences R and D / Manufacturing Opportunities</title>
		<description><![CDATA[With today&#8217;s economy we can always use whatever help is available. Here are some listings of executive level positions through Sterling-Hoffman that are yet unfilled.
*Senior Director, Analytical Technical Support (Pennsylvania)
*Director, Laboratory Operations Support Services (Ontario)
*Process Engineer (California)
]]></description>
		<link>http://www.dissolutionsolutions.net/?p=511</link>
			</item>
	<item>
		<title>USP Provides Information on Recall and Reissuance of USP 33–NF 28</title>
		<description><![CDATA[ 
USP 32–NF 27 is official at this time and remains official until further notice. USP 33–NF 28, which was released on November 1, 2009 and recalled on January 8, 2010, was not scheduled to become official until May 1, 2010 and should not be used. The current official standards in USP 32–NF 27 can [...]]]></description>
		<link>http://www.dissolutionsolutions.net/?p=506</link>
			</item>
</channel>
</rss>
